Physician profile
Barbara E Meyer
NPI 1629060520
$1,074.20
in general payments reported to CMS, 2019-2025
24 companies · $18.55 in 2025
The $18.55 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $164 · 2022: $49.49 · 2023: $18.98 · 2024: $68.83 · 2025: $18.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $193.86 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $161.67 | 2019-2020 | |
| Pfizer INC. | $140.34 | 2019-2024 | |
| Novo Nordisk INC | $130.02 | 2019-2022 | |
| Allergan, INC. | $59.33 | 2019-2020 | |
| Eisai INC. | $51.13 | 2019 | |
| Amgen INC. | $43.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.02 | 2019-2020 | |
| Ethicon US, LLC | $19.06 | 2019 | |
| Abbott Laboratories | $18.98 | 2023 | Freestyle Libre 3 |
| Organon LLC | $18.55 | 2025 | Nexplanon |
| Astellas Pharma US INC | $18.37 | 2019 | |
| Ironwood Pharmaceuticals, INC | $17.78 | 2019 | |
| Amarin Pharma, INC. | $16.05 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.60 | 2019 | |
| Phadia US INC. | $14.97 | 2019 | |
| Boston Scientific Corporation | $14.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.75 | 2019 | |
| Genentech USA, INC. | $12.54 | 2020 | |
| Optinose US, INC. | $12.52 | 2019 | |
| Lilly USA, LLC | $11.90 | 2019 | |
| Cranial Technologies, INC | $11.43 | 2019 | |
| Adlon Therapeutics L.P. | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.